⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL2125116 | 1.00 | — | — | |
| Acetonitrile SCHEMBL28017081 | 1.00 | — | — | |
| Acetonitrile SCHEMBL19211025 | 1.00 | APLNR (0.32) | — | |
| Acetonitrile SCHEMBL29125464 | 1.00 | APLNR (0.32) | — | |
| Acetonitrile SCHEMBL7316992 | 0.96 | — | — | |
| Acetonitrile SCHEMBL15092908 | 0.96 | APLNR (0.33) | — | |
| Acetonitrile SCHEMBL16267901 | 0.96 | APLNR (0.33) | — | |
| Acetonitrile SCHEMBL15092655 | 0.96 | APLNR (0.33) | — | |
| Acetonitrile SCHEMBL16267560 | 0.96 | APLNR (0.33) | — | |
| Acetonitrile SCHEMBL522737 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117563275-A | Hybrid monolithic column doped with halloysite nanotubes, and preparation method and application thereof | 宁波海关技术中心 | 2024-02-20 | — | — | CN | claimed |
| CN-117554524-A | Liquid chromatography detection method for cyanide residues in injection | 英格尔检测技术服务（上海）有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-114577934-B | Separation method and detection method of growth-promoting antibacterial drug and application of growth-promoting antibacterial drug | 中国兽医药品监察所 | 2024-01-09 | — | — | CN | claimed |
| CN-115925765-A | Separation method of hyaluronic acid oligosaccharide modified by BDDE | 华熙生物科技股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115684372-A | Method for measuring content of stachydrine hydrochloride in Naomaili granules | 南京柯菲平盛辉制药有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114577934-A | Separation method and detection method of growth-promoting antibacterial drugs and application thereof | 中国兽医药品监察所 | 2022-06-03 | — | — | CN | claimed |
| CN-111413451-B | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-112924573-B | HPLC-MS/MS detection method for Abidol, ribavirin and chloroquine | 山东英盛生物技术有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-112924573-A | HPLC-MS/MS detection method for Abidol, ribavirin and chloroquine | 山东英盛生物技术有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-111413451-A | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | 京博农化科技有限公司 | 2020-07-14 | — | — | CN | claimed |
| CN-111351879-A | LC-MS-based cell exosome lipidomics analysis method | 上海中科新生命生物科技有限公司 | 2020-06-30 | — | — | CN | claimed |
| CN-106353154-B | The method for separating and preparing of a four peptides impurity in alanyl-glutamine injection | 杭州民生药业有限公司 | 2019-01-01 | — | — | CN | claimed |
| CN-106353154-A | Separation preparation method of tetrapeptide impurity in alanyl-glutamine injection | 杭州民生药业有限公司 | 2017-01-25 | — | — | CN | claimed |
| CN-103776944-B | Method for detecting NNAL and NNA in tobacco shred and cigarette smoke | HONGYUN HONGHE TOBACCO GROUP | 2015-07-15 | — | — | CN | claimed |
| CN-103878036-A | Separation analysis or separation preparation method of alkaline compound with strong polarity | DALIAN CHEMICAL PHYSICS INST | 2014-06-25 | — | — | CN | claimed |
| CN-119177226-B | 5' -Phosphosulfate kinase mutant and application thereof | 杭州裕元生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119177226-A | 5' -Phosphosulfate kinase mutant and application thereof | 杭州裕元生物科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| WO-2010026214-A1 | PYRAZOLOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
| US-20080161288-A1 | COMPOUNDS | PFIZER INC. | 2008-07-03 | — | — | US | disclosed |
| US-20080125463-A1 | N-(1-hetarylpiperidin-4-yl)(het)arylamides as EP2 receptor modulators | BAYER SCHERING PHARMA AG (DE) | 2008-05-29 | — | — | US | disclosed |